As a global pharmaceutical company, the Daiichi Sankyo Group is uniquely positioned to address diverse social needs, including unmet medical needs. To meet these needs, we invest various forms of capital, including human and intellectual capital, and continue to take on challenges across the entire value chain by leveraging Science & Technology, our greatest strength. Through these efforts, we create value for a diverse range of stakeholders, including improving the well-being of patients with cancer and creating future hope for them.

By continuously driving this cycle of value creation, we aim to enhance our corporate value while contributing to the sustainable growth of society.

 

An enlargeable image opens in a separate window